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out, hemodynamics of coronary blood flow may be signif- 
icantly different in a dilated failing heart compared with a 
normal heart, especially in the long term after cardiom- 
yoplasty. We are currently using the Doppler guidewire 
system to evaluate long-term effects of cardiomyoplasty on
coronary arterial blood flow in canine hearts. This infor- 
mation will resolve the contradictory findings and be 
useful in clarifying the mechanisms of augmentation by 
cardiomyoplasty. 
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The role of adenosine in University of Wisconsin 
solution 
To the Editor: 
The recent article by Lasley and Mentzer 1investigating 
the role of adenosine in enhanced myocardial preserva- 
tion with University of Wisconsin (UW) solution shows 
the important role of the compound for the protective 
properties of UW solution. Functional recovery as mea- 
sured by rate-pressure product was significantly improved 
after 18 hours of cold storage with the inclusion of 
adenosine in UW solution. However, no difference was 
observed between UW solution without adenosine and St. 
Thomas' Hospital cardioplegic solution. The question 
arising is whether the inclusion of adenosine in St. Tho- 
mas' Hospital solution would have had the same beneficial 
effects on functional recovery and interstitial fluid purine 
levels. It can be concluded from the presented ata that 
no difference xists between UW solution without aden- 
osine and unmodified St. Thomas' Hospital solution and 
that the main component leading to improved preserva- 
tion is adenosine. 
Therefore, the conclusion drawn by the authors that the 
superior preservation with UW solution is a result of its 
intracellular-based lectrolyte composition and inclusion 
of lactobionate, raffinose, and hydroxyethyl starch is mis- 
leading. We have shown a dose-dependent improvement 
of myocardial recovery with the addition of adenosine to 
St. Thomas' Hospital solution No. 2 in an in vivo baboon 
model after 3 hours of cardioplegic arrest. 2 Our results, 
consistent with those of other studies, showed no benefi- 
cial effect on myocardial adenosine triphosphate content, 
stressing the fact that the effect of adenosine on improving 
postischemic refunction seems to be independent of its 
effects as an adenine nucleotide precursor. 
The assumption that the low-sodium, high-potassium 
formulation of UW solution could presumably retard cell 
swelling by reducing the electrochemical gradients of 
these ions may be correct; however, the high potassium 
concentration is possibly the cause of postischemic endo- 
thelial dysfunction as a result of endothelial damage or 
disturbance. Amrani and colleagues 3 reported a marked 
increase in coronary vascular esistance associated with 
impaired myocardial protection when using UW solution 
in an isolated rat heart model for 60 minutes of global 
ischemia at a moderately hypothermic temperature 
(20 ~ C). Loss of protection with UW solution at temper- 
atures of 20~ compared with St. Thomas' Hospital 
solution No. 2 seems to be correlated with the high 
potassium concentrations. Other groups have also re- 
ported impaired endothelium-dependent coronary re- 
sponses after cold potassium cardioplegia. 4 
These findings show that the superior preservation with 
UW solution compared with other crystalloid preservation 
solutions is not uncontradicted. Another study from the 
Universities of Cape Town and Jerusalem found superior 
long-term preservation for 18 hours of cold storage with 
St. Thomas' Hospital solution No. 2 compared with UW 
solution in a paracorporeal porcine model. 5Therefore, a
study of a fourth group with St. Thomas' Hospital solution 
and inclusion of adenosine should be performed to sub- 
stantiate the conclusions drawn by Lasley and Mentzer. 
D. H. Boehm, MD 
B. Reichart, MD 
Department of Cardiac Surgery 
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Reply to the Editor: 
We thank Drs. Boehm and Reichart for their interest in 
our recent study on the role of adenosine in University of 
Wisconsin (UW) preservation solution. 1 In these studies 
we reported that omission of adenosine from UW solution 
markedly reduced the functional recovery of isolated 
perfused rabbit hearts after 18 hours of hypothermic 
(4 ~ C) preservation. Functional recovery in hearts pre- 
served with UW solution without adenosine was similar to 
that in hearts preserved with St. Thomas' Hospital solu- 
tion. We concluded that adenosine plays a key role in the 
enhanced myocardial preservation observed with UW 
solution. 
We agree with Drs. Boehm and Reichart that the 
question remains as to whether inclusion of adenosine in 
St. Thomas' Hospital solution would have produced the 
same functional recovery as in UW solution. Addition of 
adenosine to St. Thomas' Hospital solution would have 
likely produced the same interstitial fluid profile as seen 
with UW solution and improved the preservation, but, 
because the two solutions are so different in composition, 
it is difficult to say whether the functional recovery would 
have been equivalent to that of UW solution. However, 
the purpose of this study was to determine whether 
adenosine was a necessary component of UW solution, 
not to compare the preservation capabilities of the two 
different solutions. The St. Thomas' Hospital solution 
group was included in this study merely for comparison 
purposes. 
The composition of UW solution is based on the 
complications associated with prolonged hypothermia and 
ischemia, but few studies have assessed which of these 
components play an integral role in preservation. 2 The 
results of this study indicate that adenosine is a key 
component of UW solution. In addition, Ko and col- 
leagues 3 recently reported that reversal of the sodium- 
potassium composition or omission of hydroxyethyl starch 
resulted in less preservation of diastolic function after 6 
hours preservation (1~ to 2 ~ C) of canine hearts. We agree 
that the effects of the high potassium concentration (in 
UW solution) on vascular/endothelial function must be 
studied further; however, in this study no evidence was 
found of more vascular dysfunction in hearts preserved 
with UW solution than in those preserved with St. Tho- 
mas' Hospital solution. Furthermore, in the study by 
Amrani and colleagues 4 cited by the respondents, the 
cold-storage temperature was much higher (20 ~ C) than 
that for which the UW solution was designed (4 ~ C). 
In conclusion, on the basis of experimental results, it 
appears that UW solution may be superior to St. Thomas' 
Hospital solution for prolonged myocardial preservation 
because of the inclusion of adenosine and hydroxyethyl 
starch and its intracellular-based ionic composition. How- 
ever, because clinical preservation times have remained in 
the 4 to 5 hour range for the past decade, it is evident hat 
much Work remains to be done in the area of myocardial 
preservation for heart transplantation. 
Robert D. Lasley, PhD 
Department of Surgery 
University of Wisconsin at Madison 
Madison, WI 53792 
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Invited letter concerning: Biochemical and cellular 
characterization of cardiac valve tissue after 
cryopreservation or antibiotic preservation 
(J THORAC CAROIOVASC SUING 1994;108:63-7) 
To the Editor." 
The vexing question of whether aortic valve allografts 
survive longer when their donor cell population isviable at 
implantation has been debated now for more than 20 
years. Truly conclusive vidence in favor Of maintaining 
cell viability during the preparation and storage of grafts is 
still lacking. Most follow-up studies of so-called "viable" 
valve grafts have not attempted to establish the persis- 
tence of donor cells in the explanted valves or to define 
the histologic status of the grafts. A notable exception is 
the paper of O'Brien and colleagues, 1 who demonstrated 
persistent donor cells in one single case of the series they 
studied. Despite good cellularity, however, this graft did 
not exhibit normal eaflet architecture. Without adequate 
cytologic and histologic information on the "viable" graft 
at the end of its useful life, the possibility remains 2 that 
